The new oral anticoagulants with direct action. An opportunity and a challenge

被引：0
作者：
Altman, Raul [1 ]
Daniel Gonzalez, Claudio [2 ]
机构：
[1] Ctr Trombosis Buenos Aires, Trombosis, Fac Med Tucuman, Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Escuela Med, Dept Farmacol, Buenos Aires, DF, Argentina
来源：
REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA | 2015年 / 44卷 / 02期
关键词：
New oral anticoagulants (NOACs); NOACs with direct action; Monitoring for NOACs; Laboratory assessment;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：68 / 72
页数：5
相关论文
共 10 条
  • [1] ALTMAN R, 2014, THROMB J, V12
  • [2] Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons
    Gomez-Outes, Antonio
    Isabel Terleira-Fernandez, Ana
    Luisa Suarez-Gea, M.
    Vargas-Castrillon, Emilio
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [3] The effect of dabigatran on the activated partial thromboplastin time and thrombin time as determined by the Hemoclot thrombin inhibitor assay in patient plasma samples
    Hapgood, Greg
    Butler, Jenny
    Malan, Erica
    Chunilal, Sanjeev
    Tran, Huyen
    [J]. THROMBOSIS AND HAEMOSTASIS, 2013, 110 (02) : 308 - 315
  • [4] Recent guidelines and recommendations for laboratory assessment of the direct oral anticoagulants (DOACs): is there consensus?
    Lippi, Giuseppe
    Favaloro, Emmanuel J.
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (02) : 185 - 197
  • [5] Rivaroxaban and other novel oral anticoagulants: Pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring
    Mueck W.
    Schwers S.
    Stampfuss J.
    [J]. Thrombosis Journal, 11 (1)
  • [6] Non-adherence to new oral anticoagulants: a reason for concern during long-term anticoagulation?
    Rodriguez, R. A.
    Carrier, M.
    Wells, P. S.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (02) : 390 - 394
  • [7] Laboratory assessment of rivaroxaban: A review
    Samama M.M.
    Contant G.
    Spiro T.E.
    Perzborn E.
    Le Flem L.
    Guinet C.
    Gourmelin Y.
    Rohde G.
    Martinoli J.-L.
    [J]. Thrombosis Journal, 11 (1)
  • [8] Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls
    Samama, Meyer Michel
    Contant, Genevieve
    Spiro, Theodore E.
    Perzborn, Elisabeth
    Guinet, Celine
    Gourmelin, Yves
    Le Flem, Lena
    Rohde, Gabriele
    Martinoli, Jean Luc
    [J]. THROMBOSIS AND HAEMOSTASIS, 2012, 107 (02) : 379 - 387
  • [9] ten Cate H, 2013, THROMB J, V11, DOI 10.1186/1477-9560-11-8
  • [10] Monitoring and reversal strategies for new oral anticoagulants
    Vanden Daelen, Sophie
    Peetermans, Marijke
    Vanassche, Thomas
    Verhamme, Peter
    Vandermeulen, Erik
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (01) : 95 - 103
1